Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Dysregulated coagulation associated with hypofibrinogenaemia and plasma hypercoagulability: implications for identifying coagulopathic mechanisms in humans.

Marchi R, Walton BL, McGary CS, Lin FC, Ma AD, Pawlinski R, Mackman N, Campbell RA, Di Paola J, Wolberg AS.

Thromb Haemost. 2012 Sep;108(3):516-26. doi: 10.1160/TH12-05-0355. Epub 2012 Jul 26.

2.

A novel fibrinogen Bbeta chain frameshift mutation in a patient with severe congenital hypofibrinogenaemia.

Xu X, Wu J, Zhai Z, Zhou R, Wang X, Wang H, Ding K, Sun Z, Ni H.

Thromb Haemost. 2006 Jun;95(6):931-5.

PMID:
16732370
3.

A novel natural mutation AαPhe98Ile in the fibrinogen coiled-coil affects fibrinogen function.

Riedelová-Reicheltová Z, Kotlín R, Suttnar J, Geierová V, Riedel T, Májek P, Dyr JE.

Thromb Haemost. 2014 Jan;111(1):79-87. doi: 10.1160/TH13-04-0267. Epub 2013 Oct 10.

PMID:
24108601
4.

Hypodysfibrinogenaemia due to production of mutant fibrinogen alpha-chains lacking fibrinopeptide A and polymerisation knob 'A'.

Vorjohann S, Fish RJ, Biron-Andréani C, Nagaswami C, Weisel JW, Boulot P, Reyftmann L, de Moerloose P, Neerman-Arbez M.

Thromb Haemost. 2010 Nov;104(5):990-7. doi: 10.1160/TH10-03-0161. Epub 2010 Aug 30. Erratum in: Thromb Haemost. 2011 Feb 1;105(2):386.

5.

Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.

Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.

Thromb Haemost. 1999 Feb;81(2):268-74.

PMID:
10064005
6.

Coexistence of hypofibrinogenemia and factor V Leiden mutation: is the balance shifted to thrombosis?

Miljić P, Nedeljkov-Jančić R, Zuvela M, Subota V, Dorđević V.

Blood Coagul Fibrinolysis. 2014 Sep;25(6):628-30. doi: 10.1097/MBC.0000000000000106.

PMID:
24637696
7.

A novel mutation in the FGB: c.1105C>T turns the codon for amino acid Bβ Q339 into a stop codon causing hypofibrinogenemia.

Marchi R, Brennan S, Meyer M, Rojas H, Kanzler D, De Agrela M, Ruiz-Saez A.

Blood Cells Mol Dis. 2013 Mar;50(3):177-81. doi: 10.1016/j.bcmd.2012.11.010. Epub 2012 Dec 23.

PMID:
23266225
8.

Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency.

Asselta R, Platè M, Robusto M, Borhany M, Guella I, Soldà G, Afrasiabi A, Menegatti M, Shamsi T, Peyvandi F, Duga S.

Thromb Haemost. 2015 Mar;113(3):567-76. doi: 10.1160/TH14-07-0629. Epub 2014 Nov 27.

PMID:
25427968
9.

Novel fibrinogen mutation γ314Thr→Pro (fibrinogen AI duPont) associated with hepatic fibrinogen storage disease and hypofibrinogenaemia.

Brennan SO, Davis RL, Conard K, Savo A, Furuya KN.

Liver Int. 2010 Nov;30(10):1541-7. doi: 10.1111/j.1478-3231.2010.02312.x.

PMID:
20666993
10.

Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.

Kotlín R, Suttnar J, Cápová I, Hrachovinová I, Urbánková M, Dyr JE.

Am J Hematol. 2012 May;87(5):555-7. doi: 10.1002/ajh.23162. Epub 2012 Mar 9.

11.

Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the gamma chain globular domain impairing fibrinogen secretion.

Vu D, de Moerloose P, Batorova A, Lazur J, Palumbo L, Neerman-Arbez M.

J Med Genet. 2005 Sep;42(9):e57.

12.

Fibrinogen Alès: a homozygous case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site "a".

Lounes KC, Soria C, Mirshahi SS, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J.

Blood. 2000 Nov 15;96(10):3473-9.

13.

A frameshift mutation in the human fibrinogen Aalpha-chain gene (Aalpha(499)Ala frameshift stop) leading to dysfibrinogen San Giovanni Rotondo.

Margaglione M, Vecchione G, Santacroce R, D'Angelo F, Casetta B, Papa ML, Grandone E, Di Minno G.

Thromb Haemost. 2001 Dec;86(6):1483-8.

PMID:
11776317
14.

Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain gene.

Monaldini L, Asselta R, Duga S, Peyvandi F, Ghosh K, Malcovati M, Tenchini ML.

Haematologica. 2006 May;91(5):628-33.

15.

Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia.

Homer VM, Brennan SO, Ockelford P, George PM.

Thromb Haemost. 2002 Sep;88(3):427-31.

PMID:
12353071
16.

Partial deletion of the αC-domain in the Fibrinogen Perth variant is associated with thrombosis, increased clot strength and delayed fibrinolysis.

Westbury SK, Duval C, Philippou H, Brown R, Lee KR, Murden SL, Phillips E, Reilly-Stitt C, Whalley D, Ariëns RA, Mumford AD.

Thromb Haemost. 2013 Dec;110(6):1135-44. doi: 10.1160/TH13-05-0408. Epub 2013 Sep 19.

PMID:
24048413
17.
18.

[Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].

Krause WH, Huth K, Heene DL, Lasch HG.

Klin Wochenschr. 1975 Aug 15;53(16):781-2. German.

PMID:
1165625
19.

Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo.

Kotlín R, Reicheltová Z, Suttnar J, Salaj P, Hrachovinová I, Riedel T, Malý M, Oravec M, Kvasnicka J, Dyr JE.

J Thromb Thrombolysis. 2010 Oct;30(3):311-8. doi: 10.1007/s11239-010-0505-1.

PMID:
20640913
20.

The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice.

Walton BL, Getz TM, Bergmeier W, Lin FC, Uitte de Willige S, Wolberg AS.

J Thromb Haemost. 2014 May;12(5):680-9. doi: 10.1111/jth.12534.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk